Day: June 29, 2023

OMA SAVINGS BANK PLC, STOCK EXCHANGE RELEASE 29 JUNE 2023 AT 13.30 P.M. EET, OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGEOma Savings Bank Plc updates its medium-term financial goals regarding comparable return on equity and capital adequacy At its meeting on 29 June 2023, the Board of Directors of Oma Savings Bank Plc (OmaSp or the Company) has updated its medium-term (3-5 years) financial goals as part of its strategy process and updates its medium-term return on equity and capital adequacy. The Company’s updated target level for comparable return on equity (ROE) is at least 16 percent instead of the previous 10 percent. The updated target level for the Common Equity Tier 1 (CET1) capital ratio is at least 2 percentage points above the regulatory requirement instead of the previous target of at least 14 percent....

Fashion-forward retailer extends its strong relationship with Macerich on Long IslandPrimark at Green Acres Mall Primark Opening at Green Acres Mall, A Macerich PropertySANTA MONICA, Calif., June 29, 2023 (GLOBE NEWSWIRE) — Macerich (NYSE: MAC), one of the nation’s leading owners, operators and developers of one-of-a-kind retail and mixed-use properties in top markets, today announced that Primark has opened a new Long Island store at Green Acres Mall. Irish retail brand Primark is a leading international clothing retailer that draws shoppers to the high street worldwide with its wide selection of essentials and fashion favorites built around everyday affordability. At Green Acres, Primark is located in Center Court, adjacent to another prominent international retailer scheduled to open in Fall 2023. The two retailers replace...

The Extraordinary General Meeting of Shareholders of AB “Ignitis grupė” (hereinafter – the Group), legal entity code: 301844044, registered office address: Laisvės Ave. 10, Vilnius, which was held on 29 June 2023, adopted the following resolutions: 1. Regarding agreement to the reduction of the share capital of AB “Ignitis gamyba”, a subsidiary of AB “Ignitis grupė”.1.1. To agree to the reduction of the share capital of AB “Ignitis gamyba” from EUR 187,920,762.41 (one hundred and eighty-seven million nine hundred and twenty thousand seven hundred and sixty-two euros and forty-one cents) to EUR 90,000,000.12 (ninety million euros and twelve cents) by cancelling 337,657,801 ordinary registered uncertificated shares of AB “Ignitis gamyba” with a nominal value of EUR 0.29 each. The total value of the shares to be cancelled is EUR 97,920,762.29...

The Extraordinary General Meeting of Shareholders of AB “Ignitis grupė” (hereinafter – the Group), legal entity code: 301844044, registered office address: Laisvės Ave. 10, Vilnius, which was held on 29 June 2023, adopted the following resolutions: 1. Regarding agreement to the reduction of the share capital of AB “Ignitis gamyba”, a subsidiary of AB “Ignitis grupė”.1.1. To agree to the reduction of the share capital of AB “Ignitis gamyba” from EUR 187,920,762.41 (one hundred and eighty-seven million nine hundred and twenty thousand seven hundred and sixty-two euros and forty-one cents) to EUR 90,000,000.12 (ninety million euros and twelve cents) by cancelling 337,657,801 ordinary registered uncertificated shares of AB “Ignitis gamyba” with a nominal value of EUR 0.29 each. The total value of the shares to be cancelled is EUR 97,920,762.29...

 Initiation of pivotal Phase 3 trial in non-small cell lung cancer (NSCLC) marks the first landmark in BioNTech’s and OncoC4’s strategic collaboration initiated in March 2023 with the aim to evaluate BNT316/ONC-392 in various solid tumor indications The randomized Phase 3 trial is expected to enroll approximately 600 patients with metastatic, immunotherapy-resistant NSCLC at clinical trial sites initially in the United States, followed by Europe and other countries and regions The trial initiation follows the FDA Fast Track Designation granted in 2022, based on Phase 1/2 safety and efficacy data for the monotherapy in metastatic, immunotherapy-resistant NSCLC BNT316/ONC-392 is entering the pivotal clinical evaluation as part of BioNTech’s strategy to initiate multiple trials with registrational potential in 2023 and 2024MAINZ, Germany,...

OMA SAVINGS BANK PLC STOCK EXCHANGE RELEASE, 29 JUNE 2023 AT 13.31 P.M. EET, OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGEOma Savings Bank Plc’s composition of Shareholders’ Nomination Committee According to the shareholder list on 1 June 2023, representatives of the five largest shareholders have been appointed to the Nomination Committee of Oma Savings Bank Plc (OmaSp):Raimo Härmä, appointed by Etelä-Karjalan Säästöpankkisäätiö Ari Lamminmäki, appointed by Parkanon Säästöpankkisäätiö Jouni Niuro, appointed by Liedon Säästöpankkisäätiö Aino Lamminmäki, appointed by Töysän Säästöpankkisäätiö Simo Haarajärvi, appointed by Kuortaneen SäästöpankkisäätiöThe Nomination Committee elects a Chairman from among its members. The Nomination Committee prepares proposals for the election of the Board of Directors and the...

Company Announcement 29 June 2023Announcement No. 23 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Results of rights issue NKT A/S (the Company) today announces that all 10,744,009 new shares offered under the rights issue announced by the Company on 8 June 2023 (the Offering) have been subscribed for. Approximately 98.5 % of the new shares have been subscribed for by exercise of pre-emptive subscription rights. Demand for the remaining shares has been very high and has exceeded the number of new shares not subscribed for by exercise of pre-emptive subscription rights by 37 times. On this basis and to accommodate the Company’s...

The Danish Agency for Higher Education and Science has today informed NNIT of a decision to withdraw from the contract on the Future State Educational Grant and Loan Payment System, which was awarded to NNIT on October 14, 2022, cf. company announcement no. 13/2022. The withdrawal is completed in accordance with the standard clause in the contract following constructive dialogue and cooperation with NNIT during the clarification phase, which has established that the scope of the project exceeds initial expectations and that the project consequently cannot continue in its current form. NNIT expects that the Danish Agency for Higher Education and Science will re-tender the contract and that NNIT will be part of the tender procedure. The withdrawal has no effect on NNIT’s 2023 outlook. Contact for further information Carsten RingiusEVP &...